• Mashup Score: 4

    Dupilumab treatment led to clinical asthma remission in patients with uncontrolled moderate-to-severe asthma with type 2 inflammation, according to a post hoc analysis of the LIBERTY ASTHMA QUEST study.“Asthma remission represents a clinically meaningful goal for asthma management in the era of therapeutics that target underlying disease pathobiology; the medical community is still trying

    Tweet Tweets with this article
    • Dupilumab treatment led to clinical #asthma remission in patients with uncontrolled moderate to severe asthma, according to study presented at #AAAAI21 https://t.co/Ud7CLzjFPI

  • Mashup Score: 0

    Clinicians are encouraged to team with school employees, asthma educators and patient advocates to improve the health and well-being of patients with asthma, panelists said.The speakers described three different interdisciplinary programs they spearhead during a symposium session of the American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting.

    Tweet Tweets with this article
    • Several panelists at the Annual Meeting of @AAAAI_org -- #AAAAI21 -- discussed ways to reduce asthma burden https://t.co/3MOevCt3lu

  • Mashup Score: 0

    Dupilumab treatment led to clinical asthma remission in patients with uncontrolled moderate-to-severe asthma with type 2 inflammation, according to a post hoc analysis of the LIBERTY ASTHMA QUEST study.“Asthma remission represents a clinically meaningful goal for asthma management in the era of therapeutics that target underlying disease pathobiology; the medical community is still trying

    Tweet Tweets with this article
    • Dupilumab treatment led to clinical #asthma remission in patients with uncontrolled moderate to severe asthma, according to study presented at #AAAAI21 https://t.co/Ud7CLzBgHg

  • Mashup Score: 3

    Dupilumab treatment led to clinical asthma remission in patients with uncontrolled moderate-to-severe asthma with type 2 inflammation, according to a post hoc analysis of the LIBERTY ASTHMA QUEST study.“Asthma remission represents a clinically meaningful goal for asthma management in the era of therapeutics that target underlying disease pathobiology; the medical community is still trying

    Tweet Tweets with this article
    • Dupilumab treatment led to clinical #asthma remission in patients with uncontrolled moderate to severe asthma, according to study presented at #AAAAI21 https://t.co/smktpX85kY

  • Mashup Score: 0

    Dupilumab treatment led to clinical asthma remission in patients with uncontrolled moderate-to-severe asthma with type 2 inflammation, according to a post hoc analysis of the LIBERTY ASTHMA QUEST study.“Asthma remission represents a clinically meaningful goal for asthma management in the era of therapeutics that target underlying disease pathobiology; the medical community is still trying

    Tweet Tweets with this article
    • Dupilumab treatment led to clinical #asthma remission in patients with uncontrolled moderate to severe asthma, according to study presented at #AAAAI21 https://t.co/b57ZCyw6Qu

  • Mashup Score: 0

    A panel of experts at the virtual American Academy of Allergy, Asthma and Immunology Annual Meeting highlighted current evidence on allergic reactions to available COVID-19 vaccines and how to assess patients who have had a reaction.“In the clinical trials with [the messenger RNA] vaccines involving tens of thousands of patients, there were no anaphylactic reactions reported, but on the

    Tweet Tweets with this article
    • #AAAAI21 virtual discussion focuses on allergic reactions to #COVID19 #vaccines, revaccination and more https://t.co/dl0oSqYyxb

  • Mashup Score: 3

    Patients with oral corticosteroid-dependent asthma treated with benralizumab achieved OCS elimination or reduction in those in whom adrenal insufficiency was detected, regardless of baseline eosinophil count, in the PONENTE trial.The multicenter, open-label, single-arm phase 3b trial evaluated the safety and efficacy of daily OCS dose reduction following initiation of benralizumab (Fasenra,

    Tweet Tweets with this article
    • #Benralizumab eliminated or reduced oral corticosteroid use in patients with severe #asthma or reduced use in those with #Adrenalinsufficiency , presented at the #AAAAI21 virtual annual meeting https://t.co/SXQq5X2oj4

  • Mashup Score: 0

    The cause of chronic cough remained unexplained in more than one-third of patients 3.5 years after they first presented to a primary care physician for the condition, researchers wrote. The findings were published in an online supplement to The Journal of Allergy and Clinical Immunology on Feb. 1 and presented during the American Academy of Allergy, Asthma and Immunology recent annual meeting,

    Tweet Tweets with this article
    • The cause of #chroniccough remained unexplained in more than one-third of patients 3.5 years after they first presented to a #primarycare physician for the condition researchers from @NUFeinbergMed said at #AAAAI21 @AAAAI_org https://t.co/BoQPxuD5fE